Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 70-82

  Gottlieb, Shmuel ^a,b   Boyko, Valentina ^a   Harpaz, David ^a   Hod, Hanoch ^a   Cohen, Miriam ^a   Mandelzweig, Lori ^a   Khoury, Zahi ^b   Stern, Shlomo ^b   Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b BIKUR CHOLIM HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0033165769     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00152-7     Document Type: Article

References (64)

1. Fibrinolytic Therapy Trialist (FTT) Collaborative Study Group . Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients . Lancet. 343:1994;311-322.
2. Van de Werf F. Thrombolysis for acute myocardial infarction why is there no extra benefit after hospital discharge? Circulation. 91:1995;2862-2864.
3. GUSTO-I Angiographic Investigators , Ross A.M., Coyne K.S., Moreyra E., et al. Extended mortality benefit of early postinfarction reperfusion. Circulation. 97:1998;1549-1556.
4. European Cooperative Study Group , Lendernik T., Simoons M.L., Van Es G.A., Van de Werf F., Verstreate M., Arnold A.E.R. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation. 92:1995;1110-1116.
5. Simoons M.L., Vos J., Tijssen J.G.P., et al. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction 5 year follow-up of trial conducted by the Interuniversity Cardiology Institute of the Netherlands . J Am Coll Cardiol. 14:1989;1609-1615.
6. Primary Angioplasty in Myocardial Infarction Study Group , Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
7. Participants in the National Registry of Myocardial Infarction , Rogers W.J., Bowlby L.J., Chandra N.C., et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from national registry of myocardial infarction. Circulation. 90:1994;2103-2114.
8. National Registry of Myocardial Infarction 2 Investigators , Barron H.V., Bowlby L.J., Breen T., et al. Use of reperfusion therapy for acute myocardial infarction in the United States. Data from the National Registry of Myocardial Infarction 2. Circulation. 97:1998;1150-1156.
9. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK) , Rustige J., Schiele R., Burczyk U., et al. The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J. 18:1997;1438-1446.
10. Danchin N., Vaur L., Genès N., et al. Management of acute myocardial infarction in the intensive care units in 1995 a national French survey of practice and early hospital results . J Am Coll Cardiol. 30:1997;1598-1605.
11. Israeli Thrombolytic Survey Group , Gottlieb S., Boyko V., Zahger D., et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey). J Am Coll Cardiol. 28:1996;106-113.
12. TIMI Study Group . Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial . N Engl J Med. 320:1989;618-627.
13. Rouleau J.L., Talajic M., Sussex B., et al. Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada the Canadian Assessment of Myocardial Infarction (CAMI) study . J Am Coll Cardiol. 27:1996;1119-1127.
14. French J.K., Williams B.F., Hart H.H., et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J. 312:1996;1637-1641.
15. Myocardial Infarction Audit Group , Birkhead J.S. Thrombolytic treatment for myocardial infarction an examination of practice in 39 United Kingdom hospitals . Heart. 78:1997;28-33.
16. Gruppo Italiano per lo Studio Della Sopravvivenza nell'Infarto Miocardico . GISSI-3 effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction . Lancet. 343:1994;1115-1122.
17. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group . ISIS-4 a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction . Lancet. 345:1995;669-685.
18. European Secondary Prevention Study Group . Translation of clinical trials into practice a European population-based study of the use of thrombolysis for acute myocardial infarction . Lancet. 437:1996;1203-1207.
19. National Registry of Myocardial Infarction , Gurwitz J.H., Gore J., Goldberg R.J., Rubinson M., Chandra N., Rogers W.J. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med. 124:1996;283-291.
20. Myocardial Infarction Triage and Intervention Project Investigators , Every N.R., Larson E.B., Litwin P.E., et al. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med. 329:1993;546-551.
21. Myocardial Infarction Triage and Intervention Project Investigators , Every N.R., Parsons L.S., Hlatky M., Martin J.S., Weaver W.D. A comparison of thrombolytic therapy with primary angioplasty for acute myocardial infarction. N Engl J Med. 335:1996;1253-1260.
22. Selby J.V., Fireman B.H., Lundstrom R.J., et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med. 335:1996;1888-1896.
23. GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
24. GUSTO-I Investigators , Newby L.K., Rutsch W.R., Callif R.M., et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol. 27:1996;1646-1655.
25. Lange R.A., Hillis L.D. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction. N Engl J Med. 335:1996;1311-1317.
26. GISSI-3 Investigators , Maggioni A.P., Bobbio M., Malacrida R., Franzosi M.G., Barlera S., Tognoni G. Factors influencing the non-administration of thrombolytic therapy in 17944 patients randomized to GISSI-3 trial. J Am Coll Cardiol. 27:(Suppl A):1996;246A.
27. TIMI Project Group , Weaver W.D., Litwin P.E., Martin J.S., et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 18:1991;657-662.
28. Lew A.S., Hod H., Cercek B., Shah P.K., Ganz W. Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase. Am J Cardiol. 59:1987;1-5.
29. Stone G.W., Grines C.L., Browne K.F., et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 25:1995;370-377.
30. SPRINT and the Israeli Thrombolytic Survey Group , Gottlieb S., Goldbourt U., Boyko V., et al. Improved outcome of elderly patients (≥75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. Circulation. 95:1997;342-350.
31. SPRINT and the Israeli Thrombolytic Survey Group , Gottlieb S., Goldbourt U., Barbash G., Behar S. Improvement in the prognosis of patients with myocardial infarction in the 1990s compared with the prethrombolytic era an analysis by age subgroups . Am J Geriatr Cardiol. 4:1995;17-31.
32. Cream P.A., Waters D.D., Bosch X., Pelletier G.B., Roy D., Theroux P. Angiographic findings after myocardial infarction in patients with previous bypass surgery explanations for smaller infarcts in this group compared with control patients . Circulation. 71:1985;693-698.
33. Israeli Thrombolytic Survey Group , Behar S., Gottlieb S., Hod H., et al. Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. Am J Cardiol. 73:1994;438-443.
34. Hannaford P.H.C., Kay C.R., Ferry S. Agism as explanation for sexism in provision of thrombolysis. Br Med J. 309:1994;573.
35. Pagley P.R., Yarzebski J., Goldberg R., et al. Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective. Arch Intern Med. 153:1993;625-629.
36. Maynard C., Litwin P.E., Martin J.S., Weaver W.D. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction and Intervention Registry. Arch Intern Med. 152:1992;972-976.
37. SHOCK Registry Investigators , Hochman J.S., Boland J., Sleeper L.A., et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation. 91:1995;873-881.
38. Tu J.V., Pashos C.L., Naylor C.D., et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med. 336:1997;1500-1505.
39. GUSTO Investigators , Van de Werf F., Topol E.J., Lee K.L., et al. Variations in patients management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA. 273:1995;1586-1591.
40. Pilote L., Miller D.P., Califf R.M., Rau S., Weaver W.D., Topol E.J. Determinants of the use of coronary angiography after thrombolysis for acute myocardial infarction. N Engl J Med. 335:1996;1198-1205.
41. SAVE Investigators , Rouleau J.L., Moye L.A., Pfeffer M.A., et al. A comparison of management patterns after acute myocardial infarction in Canada and United States. N Engl J Med. 328:1993;779-784.
42. Israeli Thrombolytic Survey Group , Behar S., Hod H., Benari B., et al. On-site catheterization laboratory and prognosis after acute myocardial infarction. Arch Intern Med. 155:1995;813-817.
43. GUSTO-I Investigators , Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol. 30:1997;171-179.
44. SAVE Investigators , Pfeffer M.A., Moye L.A., Braunwald E., et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA. 266:1991;528-532.
45. Krumholz H.M., Douglas P.S., Lauer M.S., Pasternak R.C. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction is there evidence for gender bias? Ann Intern Med. 116:1992;785-790.
46. Ayanian J.Z., Epstein A.M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 325:1991;221-225.
47. GUSTO-I Investigators , Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients. Circulation. 91:1995;1659-1668.
48. Gruppo Italiano per lo Studio Della Sopravvivenza nell'Infarto Miocardico (GISSI-2) , Maggioni A.P., Maseri A., Fresco C., et al. Age related increase in mortality among patients with first myocardial infarctions related with thrombolysis. N Engl J Med. 329:1993;1442-1448.
49. MILIS Study Group , Stone P.H., Muller J.E., Hartwell T., et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis . J Am Coll Cardiol. 14:1989;49-57.
50. Vaccarino V., Krumholz H.M., Berkman L.F., Horwitz R.I. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women. Circulation. 91:1995;1861-1871.
51. MITI Project Investigators , Maynard C., Weaver W.D., Litwin P.E., et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol. 72:1993;877-882.
52. ISAM Study Group . A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM) mortality, morbidity, and infarct size at 21 days . N Engl J Med. 314:1986;1465-1471.
53. GISSI Investigators , Franzosi M.G., Santoro E., De Vita, et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Results of the GISSI-1 study. Circulation. 98:1998;2659-2665.
54. Israeli Thrombolytic Survey Group , Behar S., Gottlieb S., Hod H., et al. The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy. Am J Med. 101:1996;184-191.
55. Himbert D., Juliard J.M., Steg G., et al. Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol. 71:1993;377-381.
56. Berger C.J., Murabito J.M., Evans J.C., Anderson K.M., Levy D. Prognosis after first myocardial infarction. Comparison of Q wave and non-Q wave myocardial infarction in the Framingham Heart Study. JAMA. 268:1992;1545-1551.
57. Behar S., Haim M., Hod H., et al. Long-term prognosis of patients after a Q wave versus non-Q wave first acute myocardial infarction. Eur Heart J. 17:1996;1532-1537.
58. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) . Circulation. 94:1996;2341-2350.
59. Antman E.M., Braunwald E. Acute myocardial infarction. Braunwald E., Heart Disease A Textbook of Cardiovascular Medicine . 5th ed. 1997;1259 W.B. Saunders, Philadelphia.
60. Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) , Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 338:1998;1785-1792.
61. TIMI IIIB Investigators , Anderson H.V., Cannon C.P., Stone P.H., et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trail a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction . J Am Coll Cardiol. 89:1995;1643-1650.
62. MITI Investigators , Every N., Parsons L.S., Fihn S.D., et al. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation. 96:1997;1770-1775.
63. RESCATE Investigators , Marrugat J., Sanz G., Masia R., et al. Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. J Am Coll Cardiol. 30:1997;1187-1192.
64. Israeli Thrombolytic Survey Group , Blondheim D., Gottlieb S., Behar S., Marmor A. Outcome of patients with post-infarction ischemia in hospitals with and without on-site cath labs (abstr). Eur Heart J. 19:(Suppl):1998;600.